Organon & Co. (OGN)
8.14
+0.22
(+2.78%)
USD |
NYSE |
Feb 24, 16:00
Organon Research and Development Expense (Quarterly) : 91.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.992B |
| Amphastar Pharmaceuticals, Inc. | 18.73M |
| Plus Therapeutics, Inc. | 2.436M |
| Geron Corp. | 21.07M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |